Literature DB >> 11571218

Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis.

R A Lyall1, N Donaldson, M I Polkey, P N Leigh, J Moxham.   

Abstract

Although ventilatory failure is the most common cause of death in amyotrophic lateral sclerosis (ALS) and measurement of respiratory muscle strength (RMS) has been shown to have prognostic value, no single test of strength can predict the presence of hypercapnia reliably. RMS was measured in 81 ALS patients to evaluate the relationship between tests of RMS and the presence of ventilatory failure, defined as a carbon dioxide tension > or = 6 kPa. We studied the predictive value of vital capacity (VC), static inspiratory and expiratory mouth pressures (MIP, MEP), maximal sniff oesophageal (sniff P(oes)), transdiaphragmatic (sniff P(di)) and nasal (SNP) pressure, cough gastric (cough P(gas)) pressure and transdiaphragmatic pressure after bilateral cervical magnetic phrenic nerve stimulation (CMS P(di)) to identify the risk of ventilatory failure in the whole group and in subgroups of patients with and without significant bulbar involvement. For patients without significant bulbar involvement, sniff P(di) had greatest predictive power [odds ratio (OR) 57] with specificity, sensitivity and positive and negative predictive values (PPV, NPV) of 87, 90, 74 and 95%, respectively Of the less invasive tests, per cent predicted SNP had greater overall predictive power (OR 25, specificity 85%, sensitivity 81%) than per cent predicted VC (9, 89%, 53%) and per cent predicted MIP (6, 83%, 55%). No test had significant predictive power for the presence of hypercapnia when used to measure RMS in a subgroup of patients with significant bulbar weakness. Thirty-five patients underwent polysomnography. CMS P(di), sniff P(di) and per cent predicted SNP were significantly correlated with the apnoea/hypopnoea index (AHI) (P = 0.035, 0.042 and 0.026, respectively). The correlations between AHI and per cent predicted MIP and VC were less strong (both non-significant). In ALS patients without significant bulbar involvement, novel tests of RMS have greater predictive power than conventional tests to predict hypercapnia. In particular, the non-invasive SNP is more sensitive than VC and MIP, suggesting that it could usefully be included in tests of respiratory muscle strength in ALS and will be helpful in assessing the risk of ventilatory failure. In patients with significant bulbar involvement, tests of respiratory muscle strength do not predict hypercapnia. Sleep-disordered breathing is correlated with RMS and the novel tests of RMS having the strongest relationship with the degree of sleep disturbance.

Entities:  

Mesh:

Year:  2001        PMID: 11571218     DOI: 10.1093/brain/124.10.2000

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  64 in total

Review 1.  The management of motor neurone disease.

Authors:  P N Leigh; S Abrahams; A Al-Chalabi; M-A Ampong; L H Goldstein; J Johnson; R Lyall; J Moxham; N Mustfa; A Rio; C Shaw; E Willey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

Review 2.  Management of motor neurone disease.

Authors:  R S Howard; R W Orrell
Journal:  Postgrad Med J       Date:  2002-12       Impact factor: 2.401

3.  Home mechanical ventilation: a Canadian Thoracic Society clinical practice guideline.

Authors:  Douglas A McKim; Jeremy Road; Monica Avendano; Steve Abdool; Fabien Cote; Nigel Duguid; Janet Fraser; Fracois Maltais; Debra L Morrison; Colleen O'Connell; Basil J Petrof; Karen Rimmer; Robert Skomro
Journal:  Can Respir J       Date:  2011 Jul-Aug       Impact factor: 2.409

4.  Neither serotonin nor adenosine-dependent mechanisms preserve ventilatory capacity in ALS rats.

Authors:  N L Nichols; R A Johnson; I Satriotomo; G S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2014-03-28       Impact factor: 1.931

5.  Amyotrophic lateral sclerosis: clinical management and research update.

Authors:  Jinsy Andrews
Journal:  Curr Neurol Neurosci Rep       Date:  2009-01       Impact factor: 5.081

Review 6.  ALS drug development: reflections from the past and a way forward.

Authors:  Swati Aggarwal; Merit Cudkowicz
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

Review 7.  Chronic hypoventilation syndromes and sleep-related hypoventilation.

Authors:  Sebastian Böing; Winfried J Randerath
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

8.  Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis.

Authors:  Nicole L Nichols; Genevieve Gowing; Irawan Satriotomo; Lisa J Nashold; Erica A Dale; Masatoshi Suzuki; Pablo Avalos; Patrick L Mulcrone; Jacalyn McHugh; Clive N Svendsen; Gordon S Mitchell
Journal:  Am J Respir Crit Care Med       Date:  2012-12-06       Impact factor: 21.405

9.  Effects of noninvasive ventilation on sleep outcomes in amyotrophic lateral sclerosis.

Authors:  Hans D Katzberg; Adam Selegiman; Lee Guion; Nancy Yuan; Sungho C Cho; Jonathan S Katz; Robert G Miller; Yuen T So
Journal:  J Clin Sleep Med       Date:  2013-04-15       Impact factor: 4.062

10.  Acute intermittent hypoxia induced phrenic long-term facilitation despite increased SOD1 expression in a rat model of ALS.

Authors:  Nicole L Nichols; Irawan Satriotomo; Daniel J Harrigan; Gordon S Mitchell
Journal:  Exp Neurol       Date:  2015-08-16       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.